A previous in vitro study showed that lipocalin-2 gene was one of the highly amplified genes in paclitaxel-resistant PC-3-TxR cell obtained from parent prostate cancer cell line (PC-3) [23]. The gene discussed is LCN2; the disease is Familial prostate cancer.